Sweet Earth Holdings Corporation (CNSX: SE)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
Sweet Earth Holdings Corporation (CNSX: SE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.79M.
trading between 0.10 and 0.74.
Tweenvest scores Sweet Earth Holdings Corporation across four factors: quality 6/100. Its strongest factor is quality.
SE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.79M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.09
- Dividend yield
- —
- Beta (5Y)
- 1.21
- 52-week high
- CA$0.74
- 52-week low
- CA$0.10
- Avg volume (3M)
- —
- Shares outstanding
- 12.92M
- Employees
- —
- Next earnings
- —
About Sweet Earth Holdings Corporation
Sweet Earth Holdings Corporation, based in Vancouver, Canada, specializes in the cultivation, processing, and distribution of hemp-derived cannabidiol (CBD) products to markets in the United States and Spain. The company offers a diverse range of items, including CBD and hemp-infused facial care products such as hydrating creams, oat and honey cleansers, and soothing lip balms. For body and skin wellness, their botanical and essential oil collection features balancing CBD jasmine oils, calming CBD bath salt soaks, stimulating CBD neem and turmeric scrubs, and aloe-infused CBD hand sanitizers. Sweet Earth also provides a selection of men's grooming essentials like CBD face cleansers, shaving and aftershave creams, beard and face oils, and styling balms. Complementing these offerings are general hemp products, CBD pre-rolls, and CBD dog treats formulated with ingredients such as full-spectrum hemp oil and natural beef flavor.
- ISIN
- CA87039X1179
- Listed since
- May 26, 2020
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.00 | -0.07% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.00 | -0.75% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.75 | +0.06% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.00 | +0.16% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.66 | +0.46% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.89 | -0.29% |
Figures last refreshed Aug 18, 2026.